AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.8 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme

Jun Caoa,b,1, Si Chena,1, Ping Anc, Xingqiang Wangb, Xinru Xiaoa( ), Shichao Lid( ), Ye Chenga( )
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
Department of Neurosurgery, Affiliated Ri Zhao People’s Hospital, Jining Medical College, Rizhao, Shandong 276826, China
Department of Vasculocardiology, Affiliated Ri Zhao People’s Hospital, Jining Medical College, Rizhao, Shandong 276826, China
Experimental Diagnostic Center for Infectious Diseases, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China

1 These authors contributed equally to this work and shared the first authorship.

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 12 Issue 4,
July 2025
Article number: 101431
DOI: 10.1016/j.gendis.2024.101431

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Cao J, Chen S, An P, et al. Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme. Genes & Diseases, 2025, 12(4): 101431. https://doi.org/10.1016/j.gendis.2024.101431

317

Views

3

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD
Received: 05 March 2024
Published: 10 September 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).